Cell Applications and Cyfuse Biomedical K.K. announced the North American launch of a new 3D bioprinting technique to create 3D tissue from cells utilizing Cyfuse’s robotic Regenova 3D bioprinter. San Diego, Calif.-based Cell Applications said the launch will allow them to offer pay-for-service bio-printing to make scaffold-free tissue available for research use. “In addition to customized […]
Regenerative Medicine
Polyganics wins FDA 510(k) for Neurocap
Polyganics said today it won FDA 510(k) clearance for its Neurocap device, designed to reduce neuroma formation and facilitate tissue repair. Neuromas, also known as pinched nerves or nerve tumors, are benign growths of nerve tissue that can cause pain, burning sensation, tingling or numbness, according to the company. “Neuroma-induced neuropathic pain and morbidity can […]
Leader Biomedical launches tissue processing JV with BioTiss
Leader Biomedical said today it formed an equity alliance with BioTiss GmbH to consolidate human musculoskeletal tissue processing at their Austrian facilities. Through the joint venture, Leader Biomedical will be able to further develop its eCOO tech platform, using supercritical CO2 to produce orthopedic, dental and wound-care tissue products, the company said. “For more than […]
Gore wins 510(k) for Synecore hernia repair biomaterial
W.L. Gore & Associates said today it won FDA 510(k) clearance for its Synecor biomaterial designed for open, laparoscopic and robotic single-stage hernia repairs. The Synecor biomaterial is comprised of dense monofilament polytetrafluoroethylene macroporous knit to provide strength and reduce bacteria growth, Gore’s Bio-A Web tissue scaffold and a non-porous PGA/TMC film to minimize tissue […]
Avita Medical eyes Japan, South Korea for ReCell
Avita Medical (ASX:AVH) said yesterday it inked a distribution agreement with 2 companies to bring its ReCell to the Japanese and South Korean markets. The ReCell device is designed to use the patient’s own skin cells to treat a variety of skin issues, including burns, reconstructive and cosmetic procedures, the company said. “Japan and South […]
MiMedx picks up regenerative focused Stability Biologics
MiMedx (NSDQ:MDXG) said it completed its acquisition of human tissue product provider Stability Biologics, paying $10 million at closing and saying it expected the buy to be accretive to its full year 2016 adjusted EPS. Nashville, Tenn.-based Stability Biologics produces tissue products at its national processing center in San Antonio, Texas, for use in surgical, spinal […]
GE Healthcare joins $28m investment in new stem cell R&D facility
GE Healthcare (NYSE:GE) said today it is joining a $28 million (CAD $40 million) investment in a new advanced therapeutic cell technology center in Toronto. The healthcare giant is pairing with the Federal Economic Development Agency for Southern Ontario and the Centre for Commercialization of Regenerative Medicine for the center, and will be joined by investor FedDev […]
BioLargo raises nearly $6m for wound care tech
BioLargo subsidiary Clyra Medical Technologies said Wednesday it closed a financing deal with Sanatio Capital for $750,000 equity up front and a commitment for a $5 million operating line of credit. Fund will go to support Clyra’s advanced wound care products, with the company hoping to submit FDA 510(k) applications sometime this year, according to […]
FDA clears Integra’s Omnigraft for treating diabetic foot ulcers
Integra LifeSciences (NSDQ:IART) said today it won expanded FDA approval for its Omnigraft dermal regeneration matrix, now indicated to treat diabetic foot ulcers. The device, made of silicone, cow collagen and shark cartilage, is placed over the ulcer to provide a new environment for the skin and tissue to regenerate and heal the wound, according […]
Xcede reaches out to Cook Biotech for hemostatic patch development
Dynasil subsidiary Xcede Technologies said yesterday it inked collaborative development, licensing and supply agreements with Cook Medical‘s Biotech biz to aid in the development and regulatory approval of its resorbable hemostatic patch. The hemostatic patch is being designed to control severe bleeding in surgical situations, and the company hopes to begin clinical trials of the patch some […]
Vivex Biomedical raises $6.6m in Series A
Vivex Biomedical reported it pulled in $6.6 million in a Series A equity round of convertible preferred stock, according to an SEC filing. The company is focused on cellular therapies for treating orthopedic, spinal, wound and soft tissue indications, according to its website. Marietta, Ga.-based Vivex Biomedical develops a number of regenerative medical products, including […]